+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application



Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application



Journal of Thrombosis and Haemostasis 17(4): 699-707



Murine models are widely used valuable tools to study deep vein thrombosis (VT). Leading experts in VT research came together through the American Venous Forum to develop a consensus on maximizing the utility and application of available mouse models of VT. In this work, we provide an algorithm for model selection, with discussion of the advantages, disadvantages, and applications of the main mouse models of VT. Additionally, we provide a detailed surgical description of the models with guidelines to validate surgical technique.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066639344

Download citation: RISBibTeXText

PMID: 30927321

DOI: 10.1111/jth.14413


Related references

Recurrent Deep Venous Thrombosis Is Pathologically Different From Primary Deep Venous Thrombosis: Characterization of the First Mouse Model of Recurrent Venous Thrombosis in the Inferior Vena Cava. Journal of Vascular Surgery. Venous and Lymphatic Disorders 3(1): 118-119, 2015

Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer. Cold Spring Harbor Perspectives in Biology 3(9): A009670, 2011

Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. Journal of Surgical Research 108(2): 212-221, 2002

Deep venous thrombosis of lower extremities in an Emergency Department. Utility of a clinical diagnosis model. Medicina Clinica 118(14): 529-533, 2002

Utility of venous compression in deep venous thrombosis evaluation revisited. Bratislavske Lekarske Listy 113(7): 417-420, 2012

The use of clinical assessment in the diagnosis of deep venous thrombosis. Practical application of Bayes theorem. Journal des Maladies Vasculaires 13(1): 1-3, 1988

Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis. Thrombosis Research 129(4): 514-519, 2012

Male mice have increased thrombotic potential: sex differences in a mouse model of venous thrombosis. Thrombosis Research 127(5): 478-486, 2011

Choosing a treatment for deep venous thrombosis and pulmonary embolism. Prescrire International 22(138): 131-131, 2013

Cost and utility of a low-molecular-weight heparin and unfractionated heparin for treatment of deep venous thrombosis in a Balkan country: A model analysis. Experimental and Clinical Cardiology 11(2): 111-116, 2006

The treatment of deep venous thrombosis using low-molecular heparin. Swiss Consensus Conference for the Application of Low-molecular Heparin. Schweizerische Medizinische Wochenschrift 124(5): 169-178, 1994

Role of thromboxane-dependent platelet activation in venous thrombosis: Aspirin effects in mouse model. Pharmacological Research 107: 415-425, 2016

Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thrombosis and Haemostasis 79(3): 656-662, 1998

Derivation of a risk assessment model for hospital-acquired venous thrombosis: the NAVAL score. Journal of Thrombosis and Thrombolysis 41(4): 628-635, 2016

Animal model of arterial and venous thrombosis in dogs Assessment of the efficacy of various antithrombotic strategies. FASEB Journal 10(3): A434, 1996